Skip to main navigation Skip to search Skip to main content

Factors associated with COVID-19 severity and mortality among Hispanic patients living on the USA-Mexico border

  • Jorge Cervantes
  • , Amit Sureen
  • , Gian Galura
  • , Christopher Dodoo
  • , Alok Kumar Dwivedi
  • , Mohammad Bashashati
  • , Marc Zuckerman
  • , Armando Meza

Research output: Contribution to journalArticlepeer-review

Abstract

COVID-19 has ravaged the medical, social, and financial landscape across the world, and the USA-Mexico border is no exception. Although some risk factors for COVID-19 severity and mortality have already been identified in various ethnic cohorts, there remains a paucity of data among Hispanics, particularly those living on borders. Ethnic disparities in COVID-19 outcomes in Hispanic and black populations have been reported. We sought to identify the clinical presentation, treatment, laboratory, and imaging characteristics of 82 Hispanic patients in a county hospital and describe the factors associated with rates of hospitalization, intensive care unit (ICU) admission, and mortality. The most common comorbidities were hypertension (48.8%) and diabetes mellitus (DM) (39%), both found to be associated with hospitalization and mortality, while only DM was associated with increased rate of ICU admission. Multivariable analysis showed that individuals with fever, low oxygen saturation (SpO 2), nasal congestion, shortness of breath, and DM had an increased risk of hospitalization. Individuals with fever, decreased levels of SpO 2, and advanced age were found to be associated with an increased risk of death. The most common cause of death was respiratory failure (28.9%), followed by shock (17.8%) and acute kidney injury (15.6%). Our findings are critical to developing strategies and identifying at-risk individuals in a Hispanic population living on borders. Research aiming to identify key evidence-based prognostic factors in our patient population will help inform our healthcare providers so that best interventions can be implemented to improve the outcomes of patients with COVID-19.

Original languageEnglish
Pages (from-to)819-823
Number of pages5
JournalJournal of Investigative Medicine
Volume69
Issue number4
DOIs
StatePublished - Apr 1 2021
Externally publishedYes

Bibliographical note

Publisher Copyright:
© 2021 BMJ Publishing Group. All rights reserved.

ASJC Scopus Subject Areas

  • General Medicine
  • General Biochemistry,Genetics and Molecular Biology

Keywords

  • COVID-19
  • diabetes mellitus
  • intensive care units

Fingerprint

Dive into the research topics of 'Factors associated with COVID-19 severity and mortality among Hispanic patients living on the USA-Mexico border'. Together they form a unique fingerprint.

Cite this